Alabama Neurology Associates
Homewood, Alabama, United States
Medical clinic in Homewood, Alabama
3105 Independence Dr STE 105, Birmingham, AL 35209
About Alabama Neurology Associates
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
EMD Serono Research & Development Institute, Inc.
2
Alabama Neurology Associates, PC
1
IMS HEALTH GmbH & Co. OHG
1
Mallinckrodt
1
Supernus Pharmaceuticals, Inc.
1
Clinical Trials at Alabama Neurology Associates
During the past decade, Alabama Neurology Associates conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on
average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis
2005-10-01
Unknown status
30
Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse
2015-11-24
2019-05-09
Completed
160
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
2016-02-01
2018-02-01
Completed
479
Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)
2017-11-30
2020-01-10
Completed
164
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
2020-10-26
2026-12-18
Recruiting
946
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
2020-12-03
2029-09-06
Recruiting
699
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
2021-03-17
2025-11-27
Recruiting
736
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Alabama Neurology Associates" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "EMD Serono Research & Development Institute, Inc." with 2 trials
sponsored, "Alabama Neurology Associates, PC" with 1 trials sponsored, "IMS HEALTH GmbH & Co. OHG" with 1 trials sponsored and "Mallinckrodt"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Alabama Neurology Associates"
#1 collaborator was "Biogen" with 1 trials as a collaborator, "EMD Serono" with 1 trials as a collaborator and "Mallinckrodt ARD Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Alabama Neurology Associates
According to Clinical.Site data, the most researched conditions in "Alabama Neurology Associates" are
"Multiple Sclerosis" (3 trials), "Idiopathic Parkinson Disease" (1 trials), "Multiple Sclerosis (MS)" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Alabama Neurology Associates" in a lesser frequency.
Clinical Trials Intervention Types at Alabama Neurology Associates
Most popular intervention types in "Alabama Neurology Associates" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (3 trials), "Antihistamine" (2 trials), "Fenebrutinib" (2 trials), "Methylprednisolone" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Alabama Neurology Associates
The vast majority of trials in "Alabama Neurology Associates" are
10 trials for "All" genders.
Clinical Trials Status at Alabama Neurology Associates
Currently, there are NaN active trials in "Alabama Neurology Associates".
undefined are not yet recruiting,
6 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Alabama Neurology Associates,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Alabama Neurology Associates, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".